24 completed, 3 not yet recruiting, 2 unknown, 1 active not recruiting. 31 Phase 2, 5 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 31 | Completed 24, Not yet recruiting 3, Unknown 2, Active not recruiting 1, Recruiting 1 |
| Phase 1 | 5 | Completed 5 |
| Phase 3 | 4 | Unknown 2, Completed 1, Not yet recruiting 1 |
Follow Rhinitis, Allergic, Perennial: new trials by email Literature Review of Rhinitis, Allergic, Perennial trials Research Report on Rhinitis, Allergic, Perennial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background Therapy CM512, Placebo - Perennial Allergic Rhinitis (PAR) | Phase 2 | Not yet recruiting | Beijing Keymed Biosciences Co., Ltd. | 200 | 2026-10-01 | 2026-10-22 |
| PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis Recombinant Artemisia vulgaris allergen Art v 1 with Montanide ISA-51 adjuvant, Montanide ISA-51 placebo emulsion - Rhinitis Allergic | Phase 2 | Recruiting | Kazakh National Agrarian University | 138 | 2026-05-01 | 2026-06-29 |
| Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis JYB1904, Placebo+JYB1904 - Perennial Allergic Rhinitis | Phase 2 | Not yet recruiting | Jemincare | 135 | 2026-04-01 | 2026-03-09 |
| Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis INI-2004, Placebo - Allergic Rhinitis Due to Allergens, Rhinitis Allergic | Phase 2 | Completed | Inimmune Corporation | 78 | 2026-01-19 | 2026-04-29 |
| Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract 3,000 MM09, 9,000 MM09, Placebo sublingual - Allergic Rhinitis, Allergic Asthma | Phase 2 / Phase 3 | Not yet recruiting | Inmunotek S.L. | 90 | 2023-11-01 | 2023-10-23 |
| Dupilumab Effects Against Aeroallergen Challenge Dupilumab, House Dust Mites (HDM), Placebo - Asthma, Allergic | Phase 2 | Active not recruiting | The University of Texas Health Science Center at San Antonio | 96 | 2023-03-29 | 2026-08-11 |
| Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.). - Allergic Rhinitis | Phase 2 / Phase 3 | Unknown | People's Hospital of Anshun City of Guizhou Province | 60 | 2022-12-01 | 2022-10-06 |
| Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients Tregalizumab, Placebo - Allergy to House Dust Mite, Allergic Asthma | Phase 2 | Completed | T-Balance Therapeutics GmbH | 42 | 2020-12-09 | 2022-02-08 |
| Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients Placebo solution, hdmASIT+TM - House Dust Mite Allergy | Phase 2 | Completed | ASIT Biotech S.A. | 36 | 2016-09-28 | 2017-03-29 |
| Subcutaneous Immunotherapy for Mouse in Adults Mouse Allergenic Extract - Asthma, Perennial Allergic Rhinitis | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 12 | 2015-10-01 | 2018-03-07 |
| SUBLIVAC FIX Mite Mixture Dose Tolerability Study SUBLIVAC FIX Mite mixture, Placebo - House Dust Mite Allergy | Phase 1 / Phase 2 | Completed | HAL Allergy | 81 | 2015-05-01 | 2015-12-02 |
| Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis acupuncture combined moxibustion, Loratadine - Rhinitis, Allergic, Perennial | Phase 2 | Completed | Zhao Hong | 98 | 2015-03-01 | 2018-07-18 |
| Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma SLIT tablets of HDM allergen extracts, 3 different doses (A), SLIT tablets of HDM allergen extracts, 3 different doses (B), SLIT tablets of HDM allergen extracts, 3 different doses (C) - Asthma, House Dust Mite Allergy | Phase 2 | Completed | Stallergenes Greer | 386 | 2013-09-01 | 2015-12-18 |
| Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract Prick test Dermatophagoides pteronyssinus allergen extract - Allergy Dermatophagoides Pteronyssinus, Allergic Rhinitis | Phase 2 | Completed | Laboratorios Leti, S.L. | 42 | 2013-03-01 | 2018-02-23 |
| A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627) Placebo, MK-8237 6 DU, MK-8237 12 DU - Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal | Phase 2 | Completed | ALK-Abelló A/S | 124 | 2012-10-01 | 2017-09-15 |
| Biomarkers of Cockroach Sublingual Immunotherapy 2 Cockroach Sublingual Immunotherapy (SLIT) - Low Dose, Placebo, Cockroach Sublingual Immunotherapy (SLIT) - High Dose - Asthma, Perennial Allergic Rhinitis | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 99 | 2011-05-01 | 2014-06-11 |
| Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) Bilastine - Allergic Rhinoconjunctivitis, Chronic Urticaria | Phase 1 / Phase 2 | Completed | Faes Farma, S.A. | 36 | 2010-01-01 | 2012-09-26 |
| Subcutaneous Immunotherapy With Dermatophagoides Pteronyssinus in Local Allergic Rhinitis Pangramin Plus D. pteronyssinus, Placebo - Local Allergic Rhinitis | Phase 2 | Completed | Miguel Blanca Gomez | 36 | 2010-01-01 | 2016-03-31 |
| Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis Toleromune HDM, Placebo - Allergy | Phase 2 | Completed | Circassia Limited | 50 | 2009-11-01 | 2010-11-10 |
| Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) Glycerinated German Cockroach Allergenic Extract, Placebo - Rhinitis, Allergic, Perennial, Asthma | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 54 | 2009-01-01 | 2017-03-21 |
Showing 20 of 31. Sign in to see all of them.
Dust Mite Allergy (12) · Rhinitis, Allergic (10) · Hypersensitivity (6) · Asthma (5) · Rhinitis (2) · Rhinitis, Allergic, Seasonal (2) · Chronic Urticaria (1) · Erythema (1) · Nasal Obstruction (1) · Pruritus (1) · Rhinorrhea (1) · Sneezing (1) · Urticaria (1)
Hypersensitivity, Immediate (31) · Immune System Diseases (31) · Nose Diseases (31) · Otorhinolaryngologic Diseases (31) · Respiratory Hypersensitivity (31) · Respiratory Tract Diseases (31) · Rhinitis (29) · Hypersensitivity (25) · Rhinitis, Allergic (21) · Bronchial Diseases (5) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Infections (2) · Respiratory Tract Infections (2)
Antigens, Dermatophagoides (4) · CYT003-QbG10 (2) · Duration of Therapy (1) · Fish Oils (1) · Loratadine (1) · Mometasone Furoate (1) · Shi-Bi-Lin herbal formula (1) · Sublingual Immunotherapy (1) · Urea (1) · bilastine (1) · dupilumab (1) · montelukast (1) · tregalizumab (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Cytos Biotechnology AG (2) · Organon and Co (2) · ALK-Abelló A/S (1) · ASIT Biotech S.A. (1) · Antigen Laboratories, Inc. (1) · Beijing Keymed Biosciences Co., Ltd. (1) · Capnia, Inc. (1) · China Medical University Hospital (1) · Chinese University of Hong Kong (1) · Circassia Limited (1) · Faes Farma, S.A. (1) · GlaxoSmithKline (1) · HAL Allergy (1) · Inimmune Corporation (1)
United States (6) · Germany (5) · China (3) · Canada (2) · Spain (2) · Argentina (1) · Australia (1) · France (1) · Hong Kong (1) · Kazakhstan (1) · Poland (1) · Sweden (1) · Switzerland (1) · Taiwan (1) · Thailand (1)
Philipp Mueller, MD (2) · Robert Wood, MD (2) · Stefan Zielen, Prof. Dr. (2) · Amy Schaberg, B.S.N. (1) · Chengshuo Wang (1) · Fangming Chen, MB (1) · Guangjun Tang, MD (1) · Gunilla Hedlin, Prof. Dr. (1) · Jacques Hebert, MD (1) · Jorge Fernando Maspero, MD, PhD (1) · Lennart Nordvall, Prof. Dr (1) · Liu Baoyan, Master (1)
PMID 24184147, PMID 12668793, PMID 14674933, PMID 15313870, PMID 15461603, PMID 15516669, PMID 15750716, PMID 15898976, PMID 16930249, PMID 18331513, PMID 18566548, PMID 18946234, PMID 19925886, PMID 19968632, PMID 20545698, PMID 20816182, PMID 21122901, PMID 21783242, PMID 22224763, PMID 22627366, PMID 23348417, PMID 23791985, PMID 24631153, PMID 24679069, PMID 25171868, PMID 25644617, PMID 26141263, PMID 26874355, PMID 26922931, PMID 26932169, PMID 26949057, PMID 27008542, PMID 27363578, PMID 27979028, PMID 28602936, PMID 28785597, PMID 28917723, PMID 29214012, PMID 29656145, PMID 29771013, PMID 29774680, PMID 30142344, PMID 30233198, PMID 30263032, PMID 30323863, PMID 32926419, PMID 33273461, PMID 9042022
2008 (1), 2009 (1), 2016 (1), U01AI158460 (1)